Literature DB >> 5158836

The long-term treatment of hypertension with thiazide diuretics.

D G Beevers, M Hamilton, J E Harpur.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5158836      PMCID： PMC2467325          DOI： 10.1136/pgmj.47.552.639

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  6 in total

1.  EFFECTS OF ORAL DIURETICS ON RAISED ARTERIAL PRESSURE.

Authors:  W I CRANSTON; B E JUEL-JENSEN; A M SEMMENCE; R P JONES; J A FORBES; L M MUTCH
Journal:  Lancet       Date:  1963-11-09       Impact factor: 79.321

2.  Drug-induced diabetes.

Authors:  C T DOLLERY; B L PENTECOST; N A SAMAAN
Journal:  Lancet       Date:  1962-10-13       Impact factor: 79.321

3.  Some aspects of the long-term treatment of severe hypertension with methyldopa.

Authors:  M Hamilton
Journal:  Postgrad Med J       Date:  1968-01       Impact factor: 2.401

4.  Potassium loss with thiazide therapy.

Authors:  R F Maronde; M Milgrom; J M Dickey
Journal:  Am Heart J       Date:  1969-07       Impact factor: 4.749

5.  Hypertension and hyperuricaemia.

Authors:  A Breckenridge
Journal:  Lancet       Date:  1966-01-01       Impact factor: 79.321

6.  Body composition changes in hypertensive subjects on long-term oral diuretic therapy.

Authors:  J J Healy; T J McKenna; B S Canning; T G Brien; G J Duffy; F P Muldowney
Journal:  Br Med J       Date:  1970-03-21
  6 in total
  17 in total

Review 1.  Thiazides in the 1990s.

Authors:  M Orme
Journal:  BMJ       Date:  1990-06-30

Review 2.  Diuretics. Clinical pharmacology and therapeutic use (Part II).

Authors:  A Lant
Journal:  Drugs       Date:  1985-02       Impact factor: 9.546

3.  Pharmacokinetics of a single oral dose of hydroflumethiazide in health and in cardiac failure.-.

Authors:  O Brørs; S Jacobsen; E Arnesen
Journal:  Eur J Clin Pharmacol       Date:  1978-11-09       Impact factor: 2.953

4.  Pharmacokinetics of hydroflumethiazide during repeated oral administration to healthy subjects.

Authors:  O Brørs; S Jacobsen
Journal:  Eur J Clin Pharmacol       Date:  1979-05-21       Impact factor: 2.953

5.  Lack of effect of bumetanide on body potassium content in hypertension.

Authors:  L E Murchison; P D Bewsher
Journal:  Br J Clin Pharmacol       Date:  1975-02       Impact factor: 4.335

6.  A double-blind comparison of the effects of hydrochlorothiazide and tienylic acid (a diuretic with uricosuric properties) in hypertension.

Authors:  A H Gillies; T O Morgan
Journal:  Br J Clin Pharmacol       Date:  1978-10       Impact factor: 4.335

7.  Lipid profile studies in long term thiazide treated hypertensives.

Authors:  R A Rao; B M Hegde; E K Bhat; U Vidyavathi; R R Rao
Journal:  Postgrad Med J       Date:  1991-07       Impact factor: 2.401

8.  Fluorometric determination of hydroflumethiazide in human plasma and urine after its oral administration.

Authors:  O Brors; S Jacobsen; E Arnesen
Journal:  Eur J Clin Pharmacol       Date:  1977-01-03       Impact factor: 2.953

9.  Treatment of benign essential hypertension: comparison of furosemide and hydrochlorothiazide.

Authors:  K Valmin; T Hansen
Journal:  Eur J Clin Pharmacol       Date:  1975-08-14       Impact factor: 2.953

10.  Total exchangeable potassium in response to amiloride.

Authors:  V R Pearce; A C Antcliff; D G Beevers; M Hamilton
Journal:  Postgrad Med J       Date:  1978-08       Impact factor: 2.401
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.